1. |
Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. N Engl J Med, 2000, 342(5): 301-307.
|
2. |
Imagawa A, Hanafusa T, Iwahashi H, et al. Uniformity in clinical and HLA-DR status regardless of age and gender within fulminant type 1 diabetes. Diabetes Res Clin Pract, 2008, 82(2): 233-237.
|
3. |
Imagawa A, Hanafusa T, Awata T, et al. Report of the Committee of the Japan Diabetes Society on the research of fulminant and acute-onset type 1 diabetes mellitus: new diagnostic criteria of fulminant type 1 diabetes mellitus (2012). J Diabetes Investig, 2012, 3(6): 536-539.
|
4. |
王晓晶, 王彤, 于淼, 等. 12例暴发性1型糖尿病临床特征分析. 中国糖尿病杂志, 2018, 26(1): 69-73.
|
5. |
王柏荣, 陆志强, 李晓牧, 等. 新发暴发型1型糖尿病中糖化白蛋白/HbA1C比值与血糖波动幅度的相关性研究. 中华内分泌代谢杂志, 2017, 33(4): 326-329.
|
6. |
Ying L, Ma X, Lu J, et al. Fulminant type 1 diabetes: the clinical and continuous glucose monitoring characteristics in Chinese patients. Clin Exp Pharmacol Physiol, 2019, 46(9): 806-812.
|
7. |
Wang J, Liu BL, Li Z, et al. The characteristics of blood glucose fluctuations in patients with fulminant type 1 diabetes mellitus in the stable stage. Arch Endocrinol Metab, 2018, 62(6): 585-590.
|
8. |
朱文华, 钟绍, 潘颖, 等. 暴发性1型糖尿病7例诊治分析. 内科急危重症杂志, 2017, 23(5): 413-414.
|
9. |
孙致连, 李红晖, 唐平, 等. 暴发性1型糖尿病的临床研究. 广东医学, 2016, 37(z2): 57-58.
|
10. |
谢新荣, 钟慕贤, 黄普好. 新发暴发性1型糖尿病与经典1型糖尿病及成人隐匿性自身免疫性糖尿病的临床特征比较. 中国糖尿病杂志, 2021, 29(10): 754-757.
|
11. |
王毅, 巩纯秀, 曹冰燕, 等. 儿童与青少年暴发性1型糖尿病与经典1型糖尿病的区别. 中华实用儿科临床杂志, 2015, 30(8): 580-584.
|
12. |
Yang D, Zhou Y, Luo S, et al. Clinical characteristics of fulminant type 1 diabetes compared with typical type 1 diabetes: one-year follow-up study from the Guangdong T1DM Translational Medicine Study. J Diabetes Res, 2020, 2020: 8726268.
|
13. |
Moreau C, Drui D, Arnault-Ouary G, et al. Fulminant type 1 diabetes in Caucasian: a report of three cases. Diabetes Metab, 2008, 34(5): 529-532.
|
14. |
张弛, 周智广, 张冬梅, 等. 急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征. 中华医学杂志, 2005, 85(14): 967-971.
|
15. |
Luo S, Zhang Z, Li X, et al. Fulminant type 1 diabetes: a collaborative clinical cases investigation in China. Acta Diabetol, 2013, 50(1): 53-59.
|
16. |
Shimizu I, Makino H, Imagawa A, et al. Clinical and immunogenetic characteristics of fulminant type 1 diabetes associated with pregnancy. J Clin Endocrinol Metab, 2006, 91(2): 471-476.
|
17. |
Liu L, Mao J, Lu Z, et al. Clinical characteristics of fulminant type 1 diabetes associated with pregnancy in China. Endocrine, 2011, 40(3): 408-412.
|
18. |
王娜, 李晓赟, 许永良. 妊娠相关性暴发性1型糖尿病与经典1型糖尿病的对比. 浙江实用医学, 2019, 24(1): 28-29,62.
|
19. |
Matsuura N, Yoshino S, Morisaki H. A case of fulminant type 1 diabetes masquerading acute pancreatitis. J Gen Fam Med, 2017, 18(1): 32-34.
|
20. |
Liu L, Zeng L, Sang D, et al. Recent findings on fulminant type 1 diabetes. Diabetes Metab Res Rev, 2018, 34(1).
|
21. |
Hosokawa Y, Hanafusa T, Imagawa A. Pathogenesis of fulminant type 1 diabetes: genes, viruses and the immune mechanism, and usefulness of patient-derived induced pluripotent stem cells for future research. J Diabetes Investig, 2019, 10(5): 1158-1164.
|
22. |
吴晗, 方兴宇, 于淼, 等. 单中心22例暴发性1型糖尿病临床特征分析. 中华糖尿病杂志, 2018, 10(9): 590-595.
|
23. |
Liu L, Jia W, Wu Y, et al. Plasma glucose to glycated hemoglobin ratio: method of differentiating fulminant type 1 diabetes from diabetic ketoacidosis. Ann Endocrinol (Paris), 2019, 80(1): 16-20.
|